1. Home
  2. Health Information
  3. Pharmaceutical Services
  4. Application for authority to prescribe a drug of addiction
Print this page Reduce font size Increase font size

Application for authority to prescribe a drug of addiction

Summary

Under Section 28 of the Poisons and Therapeutic Goods Act 1966, the authority of the NSW Ministry of Health is required:

  1. to prescribe for, or supply to, a drug dependent person any drug of addiction (Schedule 8), or
  2. to prescribe for, or supply to, any person other than a drug dependent person, for therapeutic use by that person continuously for more than two months, any of the following drugs of addiction – buprenorphine (excluding transdermal patches), flunitrazepam, hydromorphone, methadone or any injectable drug of addiction, or
  3. to prescribe for, or supply to, any person any preparation of dexamphetamine or methylphenidate*.

An Application for Authority to Prescribe a Drug of Addiction - Form 1 - is to be used for the purposes of applying for an authority from the Ministry.  Form 1 may be completed electronically using Adobe Reader. (The latest version of Adobe Reader can be downloaded for free from Adobe).  Save the form to a local hard drive before typing in details.


(*Note, separate forms are required to apply for authorisation to prescribe dexamphetamine or methylphenidate for Attention Deficit Hyperactivity Disorder.  Click here.)


Completed forms are to be faxed to Pharmaceutical Services on (02) 98595175 or posted to Pharmaceutical Services, NSW Ministry of Health, PO Box 103, Gladesville NSW 1675.


For assistance or further information telephone the Monitoring and Compliance Section, Pharmaceutical Services, during business hours on (02) 98795239.


 

File link: Application for authority to prescribe a drug of addiction (Form 1)
File Format: PDF
File size: 124Kb
Type: Form
Date of Publication: 23 January 2012
Author Branch: Pharmaceutical Services

Application for authority to prescribe a drug of addiction
Print this page Reduce font size Increase font size

This web page and associated resource are managed and authorised by Pharmaceutical Services of Clinical Safety, Quality and Governance of the NSW Department of Health. Last updated: 1 March, 2012